Condor Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,652
| Closed | -$748K | – | 415 |
|
|
2021
Q3 | $748K | Hold |
15,652
| – | – | 0.08% | 155 |
|
|
2021
Q2 | $779K | Hold |
15,652
| – | – | 0.09% | 149 |
|
|
2021
Q1 | $698K | Hold |
15,652
| – | – | 0.08% | 146 |
|
|
2020
Q4 | $720K | Hold |
15,652
| – | – | 0.09% | 141 |
|
|
2020
Q3 | $736K | Hold |
15,652
| – | – | 0.11% | 137 |
|
|
2020
Q2 | $798K | Hold |
15,652
| – | – | 0.12% | 130 |
|
|
2020
Q1 | $741K | Hold |
15,652
| – | – | 0.14% | 125 |
|
|
2019
Q4 | $919K | Sell |
15,652
-285
| -2% | -$16.7K | 0.13% | 133 |
|
|
2019
Q3 | $850K | Sell |
15,937
-285
| -2% | -$15.2K | 0.13% | 133 |
|
|
2019
Q2 | $811K | Hold |
16,222
| – | – | 0.13% | 134 |
|
|
2019
Q1 | $847K | Hold |
16,222
| – | – | 0.14% | 133 |
|
|
2018
Q4 | $775K | Hold |
16,222
| – | – | 0.14% | 132 |
|
|
2018
Q3 | $815K | Buy |
16,222
+2
| +0% | +$100 | 0.15% | 125 |
|
|
2018
Q2 | $817K | Sell |
16,220
-285
| -2% | -$14.4K | 0.16% | 123 |
|
|
2018
Q1 | $806K | Hold |
16,505
| – | – | 0.17% | 121 |
|
|
2017
Q4 | $732K | Hold |
16,505
| – | – | 0.15% | 124 |
|
|
2017
Q3 | $838K | Hold |
16,505
| – | – | 0.17% | 120 |
|
|
2017
Q2 | $890K | Hold |
16,505
| – | – | 0.19% | 113 |
|
|
2017
Q1 | $870K | Hold |
16,505
| – | – | 0.19% | 113 |
|
|
2016
Q4 | $794K | Hold |
16,505
| – | – | 0.18% | 122 |
|
|
2016
Q3 | $890K | Sell |
16,505
-68
| -0.4% | -$3.67K | 0.21% | 111 |
|
|
2016
Q2 | $898K | Hold |
16,573
| – | – | 0.21% | 112 |
|
|
2016
Q1 | $840K | Hold |
16,573
| – | – | 0.2% | 116 |
|
|
2015
Q4 | $836K | Hold |
16,573
| – | – | 0.2% | 117 |
|
|
2015
Q3 | $797K | Hold |
16,573
| – | – | 0.21% | 119 |
|
|
2015
Q2 | $863K | Sell |
16,573
-20
| -0.1% | -$1.04K | 0.21% | 118 |
|
|
2015
Q1 | $957K | Buy |
+16,593
| New | +$957K | 0.23% | 116 |
|